According to the latest report by IMARC Group, titled “Sternal Closure Systems Market Report by Procedure (Median Sternotomy, Hemisternotomy, Bilateral Thoracosternotomy, and Others), Product (Closure Devices, Bone Cement), Material (Titanium, Polyether Ether Ketone (PEEK), Stainless Steel, and Others), End User (Hospitals and Clinics, Research Institutes, and Others), and Region 2025-2033,” the global sternal closure systems market size reached USD 2.8 Billion in 2024. Sternal closure systems refer to orthopedic devices that are used to stabilize and repair fractures of the anterior chest wall post-surgical procedures. These systems are further designed to support and close the sternum following sternotomies and sternal reconstruction procedures to promote fusion. Sternal closure systems include plates, wires, screws, and cables as standard devices that are manufactured from titanium and stainless steel materials, which ensure sternal immobility and prevent the risk of infections in bones. Apart from this, sternal closure systems help to enhance bone stability, promote healing, decrease postoperative complications, lessen the occurrence of deep sternal wound dehiscence in patients and reduce discomfort or pain while ensuring faster recovery. Based on these properties, sternal closure systems are utilized in median sternotomy, thoracosternotomy, and hemisternotomy procedures.
Global Sternal Closure Systems Market Trends:
The rising frequency of cardiovascular diseases (CVDs), especially amongst the geriatric population, has facilitated the number of open-heart surgeries, which is primarily driving the global sternal closure systems market toward growth. Moreover, the extensive utilization of median sternotomy procedures by medical practitioners has further contributed to the widespread adoption of sternal closure systems in the healthcare sector, which, in turn, is acting as another growth-inducing factor. Additionally, the advent of self-locking techniques to reduce reoperation risk and facilitate implant application and the escalating usage of biocompatible polymers, including tritium, nitonal, and polyetheretherketone (PEEK) for composing sternal closure systems are propelling the market growth. Furthermore, growing investments in public healthcare infrastructure and the development of minimal invasive median sternotomy procedures are favoring the market growth. Looking forward, the market value is projected to reach USD 4.7 Billion by 2033, expanding at a CAGR of 5.7% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Procedure, Product, Material, End User, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Abyrx Inc., Acute Innovations (Acumed LLC), B. Braun Melsungen AG (B. Braun Holding GmbH & Co.KG), IDEAR S.R.L., Jace Medical LLC, Jeil Medical Corporation, Johnson & Johnson, Kinamed Incorporated, KLS Martin Group, Orthofix Holdings Inc. and Zimmer Biomet |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800